Advertisement
Journal of Oncology Practice  
Search for:
Limit by:
  Browse by Topic or Issue
Home Search or Browse JOP Subscriptions PDA Services E-mail Alerts Customer Service

Journal of Oncology Practice, Vol 5, No 5 (September), 2009: pp. 233-235
© 2009 American Society of Clinical Oncology.
DOI: 10.1200/JOP.091013

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response to this article
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Related articles in JOP
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eng, C.
Right arrow Articles by Kopetz, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Eng, C.
Right arrow Articles by Kopetz, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Commentary

Commentary: Practice Patterns and Potential Impact on Quality Measures for a Practicing Physician

Cathy Eng, MD, FACP, Scott Kopetz, MD

Because this article has no abstract, we have provided an extract of the first 100 words of the full text.

Practicing physicians make multiple difficult treatment decisions daily. Several influences may affect choice of therapy, including consensus recommendations of the practice, ASCO or National Comprehensive Cancer Network guidelines, medical insurance coverage, geographic location of the practice, data from recently published or presented clinical trials, and familiarity with chemotherapeutic or biologic agent. Given the US Food and Drug Administration (FDA) approval of seven therapeutic agents in metastatic colorectal cancer, various treatment combinations may be considered. Practice patterns vary significantly within individual practices and may be more pronounced when comparing community versus academic settings.

Zafar et al1 have approached capturing community practice . . . [Click for More]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related articles in JOP:

Longitudinal Patterns of Chemotherapy Use in Metastatic Colorectal Cancer
S. Yousuf Zafar, Jennifer E. Marcello, Jane L. Wheeler, Krista L. Rowe, Michael A. Morse, James E. Herndon, II, and Amy P. Abernethy
JOP 2009 5: 228-233. [Abstract] [Full Text]  





About
JOP
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 Site Map

Copyright © 2009 by the American Society of Clinical Oncology, Online ISSN: 1935-469X. Print ISSN: 1554-7477
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JOP Online